Healthcare provider profile · identity verified

Gregory A Miller, MD

Family Practice · LEBANON, MO · NPI 1891899829

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	291	77
Levothyroxine Sodium	Levothyroxine Sodium	289	59
Amlodipine Besylate	Amlodipine Besylate	230	60
Lisinopril	Lisinopril	212	59
Losartan Potassium	Losartan Potassium	211	48
Sertraline Hcl	Sertraline Hcl	161	29
Pantoprazole Sodium	Pantoprazole Sodium	139	39
Metoprolol Succinate	Metoprolol Succinate	134	29
Omeprazole	Omeprazole	125	34
Carvedilol	Carvedilol	120	26
Gabapentin	Gabapentin	112	32
Lovastatin	Lovastatin	111	35
Potassium Chloride	Potassium Chloride	102	23
Furosemide	Furosemide	88	25
Tamsulosin Hcl	Tamsulosin Hcl	86	18
Metformin Hcl	Metformin Hcl	84	22
Meloxicam	Meloxicam	82	21
Alendronate Sodium	Alendronate Sodium	79	23
Trazodone Hcl	Trazodone Hcl	74	18
Prednisone	Prednisone	71	41
Eliquis	Apixaban	69	19
Rosuvastatin Calcium	Rosuvastatin Calcium	67	16
Famotidine	Famotidine	64	13
Hydrochlorothiazide	Hydrochlorothiazide	64	14
Donepezil Hcl	Donepezil Hcl	63	11
Duloxetine Hcl	Duloxetine Hcl	62	suppressed
Buspirone Hcl	Buspirone Hcl	60	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	57	15
Simvastatin	Simvastatin	57	15
Temazepam	Temazepam	57	suppressed
Pregabalin	Pregabalin	56	suppressed
Ozempic	Semaglutide	55	suppressed
Testosterone Cypionate	Testosterone Cypionate	55	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	54	suppressed
Farxiga	Dapagliflozin Propanediol	53	15
Jardiance	Empagliflozin	52	12
Trulicity	Dulaglutide	50	suppressed
Allopurinol	Allopurinol	49	14
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	47	14
Hydralazine Hcl	Hydralazine Hcl	46	suppressed
Methotrexate	Methotrexate Sodium	46	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	45	23
Memantine Hcl	Memantine Hcl	44	suppressed
Clopidogrel	Clopidogrel Bisulfate	39	11
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	36	36
Diclofenac Sodium	Diclofenac Sodium	35	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	35	suppressed
Citalopram Hbr	Citalopram Hydrobromide	34	11
Metformin Hcl Er	Metformin Hcl	34	suppressed
Lorazepam	Lorazepam	33	suppressed
Montelukast Sodium	Montelukast Sodium	33	suppressed
Ropinirole Hcl	Ropinirole Hcl	33	12
Isosorbide Mononitrate Er	Isosorbide Mononitrate	31	suppressed
Warfarin Sodium	Warfarin Sodium	31	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	29	suppressed
Chlorthalidone	Chlorthalidone	28	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	27	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	27	21
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	26	suppressed
Fluticasone Propionate	Fluticasone Propionate	26	suppressed
Paroxetine Hcl	Paroxetine Hcl	26	suppressed
Tramadol Hcl	Tramadol Hcl	26	15
Xarelto	Rivaroxaban	26	suppressed
Finasteride	Finasteride	25	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	24	suppressed
Ezetimibe	Ezetimibe	24	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	23	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	23	suppressed
Tizanidine Hcl	Tizanidine Hcl	23	suppressed
Irbesartan	Irbesartan	22	suppressed
Clonidine Hcl	Clonidine Hcl	21	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	20	suppressed
Amoxicillin	Amoxicillin	20	13
Atenolol	Atenolol	20	suppressed
Pravastatin Sodium	Pravastatin Sodium	20	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	19	19
Spironolactone	Spironolactone	18	suppressed
Sucralfate	Sucralfate	18	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	18	suppressed
Myrbetriq	Mirabegron	16	suppressed
Nystatin	Nystatin	16	11
Oxybutynin Chloride	Oxybutynin Chloride	16	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	16	suppressed
Propranolol Hcl	Propranolol Hcl	16	suppressed
Telmisartan	Telmisartan	16	suppressed
Levetiracetam	Levetiracetam	15	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	15	suppressed
Nifedipine Er	Nifedipine	15	suppressed
Benazepril Hcl	Benazepril Hcl	14	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	14	suppressed
Eszopiclone	Eszopiclone	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	14	suppressed
Ventolin Hfa	Albuterol Sulfate	14	suppressed
Bupropion Xl	Bupropion Hcl	13	suppressed
Colestipol Hcl	Colestipol Hcl	13	suppressed
Enbrel	Etanercept	13	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	13	suppressed
Mirtazapine	Mirtazapine	13	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	13	suppressed
Vyvanse	Lisdexamfetamine Dimesylate	13	suppressed
Cephalexin	Cephalexin	12	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	12	suppressed
Folic Acid	Folic Acid	12	suppressed
Naproxen	Naproxen	12	suppressed
Acarbose	Acarbose	11	suppressed
Celecoxib	Celecoxib	11	suppressed
Clonazepam	Clonazepam	11	suppressed
Diclofenac Potassium	Diclofenac Potassium	11	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	11
Entresto	Sacubitril/Valsartan	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Glipizide	Glipizide	11	suppressed
Glipizide Er	Glipizide	11	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	11	suppressed
Latanoprost	Latanoprost	11	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error